Abaxis Reports Record Revenues and Operating Income for the Second Quarter of F... (NC. Condensed Consolidated Statements...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009

Date:10/27/2008

NC.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

Three Months Ended Six Months Ended

September 30, September 30,

2008 2007 2008 2007

Revenues $27,688 $25,192 $52,260 $48,123

Cost of revenues 12,346 11,335 23,415 21,250

Gross profit 15,342 13,857 28,845 26,873

Operating expenses:

Research and development 2,082 1,822 4,079 3,475

Sales and marketing 6,494 6,381 12,321 11,610

General and administrative 1,952 1,538 3,614 3,189

Total operating expenses 10,528 9,741 20,014 18,274

Income from operations 4,814 4,116 8,831 8,599

Interest and other income (expense),

net 326 529 788 1,028

Income before income taxes 5,140 4,645 9,619 9,627

Income tax provision 1,843 1,757 3,546 3,641

Net income $3,297 $2,888 $6,073 $5,986

Net income per share:

Basic net income per share $0.15 $0.13 $0.28 $0.28

Diluted net income per share $0.15 $0.13 $0.27 $0.27

Shares used in the calculation of net

income per share:

Weighted average common shares

outstanding - basic 21,779 21,448 21,757 21,380

Weighted average common shares

outstanding - diluted 22,304 22,110 22,363 22,103

ABAXIS, INC.

Condensed Consolidated Balance Sheets

(Unaudited and in thousands)

'/>"/>

SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
2. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
3. Abaxis to Report Third Quarter Fiscal 2008 Financial Results Thursday, January 31, 2008
4. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
5. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
6. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
7. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
8. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
9. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
10. Aware, Inc. Reports Third Quarter 2008 Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009

Post Your Comments:

(Date:12/16/2009)... Soy Peptone. HSP A has been found to be effectinve ... ... December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a ... rates and yields. HSP-A has been found to be especially ...

(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, The Future of Orphan ... Pipeline Analysis and Reimbursement ,, ... Summary ,, The author has ... Orphan Diseases Therapeutics - Market Forecasts to ...

(Date:12/15/2009)... NeedleProbes™ for Atomic Force Microscopy (AFM) have been developed ... studies at the liquid/air interface. The NeedleProbes’ cylindrical geometry ... evaporation rate and viscosity - all in a single force ... ... 15, 2009 -- New, constant diameter NeedleProbes are ...

[0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM

... Aug. 2 "The federal government,s ability to,more exactly measure ... is a great statistical tool -- but that is all ... remind us that HIV/AIDS continues,to be a real public health ... around the globe. Despite recent setbacks in developing,an effective vaccine ...

... Aug. 1 Medivation, Inc.,(Nasdaq: MDVN ) today ... will present at the BMO Capital Markets 2008 Focus ... Eastern Time at,the Millennium Broadway Hotel in New York., ... and its clinical,development programs for Dimebon for Alzheimer,s and ...

... SUNRISE, Fla., Aug. 1 Bioheart, Inc. (Nasdaq:,BHRT) today ... will present a corporate overview Thursday, August 21, 2008 ... at the Marriott,Marquis in New York. A live audio ... by visiting and registering to attend at:, http://www.redchip.com ., ...

Other Biology Technology:Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5 2 Bioheart, Inc. to Present at Red Chip Investor Conference in New York 2

A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5 Bioheart, Inc. to Present at Red Chip Investor Conference in New York

(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... solutions, today announced that SC Magazine, one ... named BIO-key International the 2009 Innovator of ... Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) ... SC Magazine, "Biometric providers have been trying ...

(Date:12/15/2009)... GAINESVILLE, Fla. When treating devastating brain diseases such ... medical bags to find something to help a patient. ... to help the vast majority of patients with ataxia ... and coordination. , University of Florida neurologists are trying ... million Challenge grant from the National Institute of Neurological ...

(Date:12/15/2009)... woolly mammoths and ancient American horses may have ... thousand years longer than previously thought. After plucking ... a team of researchers used cutting-edge techniques to ... permafrost samples dated to between 7,600 and 10,500 ... least one population of these now-extinct mammals endured ...

Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2 BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3 UF to lead national effort to help patients with rare brain disease 2 UF to lead national effort to help patients with rare brain disease 3 Late-surviving megafauna exposed by ancient DNA in frozen soil 2 Late-surviving megafauna exposed by ancient DNA in frozen soil 3 Late-surviving megafauna exposed by ancient DNA in frozen soil 4 Researchers show how to divide and conquer social network of cells 60985 1 Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 1 Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 2 Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 3 Book by UC Riverside biologist explains Darwins Origin of Species 60979 1 Book by UC Riverside biologist explains Darwins Origin of Species 60979 2

[0] BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine [0] UF to lead national effort to help patients with rare brain disease [1] Late-surviving megafauna exposed by ancient DNA in frozen soil

... . , People with tomorrow,s prosthetic hands ... and touch through a series of developments by researchers ... ORNL research groups, Ilia Ivanov and Dave Geohegan of ... Simpson of the superhydrophobic materials group, are combining superhydrophobic ...

... production and base operations have left the U.S. Department of ... sites contaminated with highly toxic substances. , University of Tennessee ... have been awarded $1.3 million over three years to find ... effectively while keeping costs to a minimum. , ...

... genetically engineered corn--called Bt corn--may damage the ecology of streams ... previously considered by regulators. The study, which was funded by ... of The Proceedings of the National Academy of Sciences. ... Bt corn may travel long distances in streams and may ...

Other Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, October 2007 2 UT researcher earns $1.3M grant to study toxic cleanup at DOD sites 2 UT researcher earns $1.3M grant to study toxic cleanup at DOD sites 3 Genetically engineered corn may harm stream ecosystems 2 Genetically engineered corn may harm stream ecosystems 3

Story tips from the Department of Energy's Oak Ridge National Laboratory, October 2007 UT researcher earns $1.3M grant to study toxic cleanup at DOD sites Genetically engineered corn may harm stream ecosystems

ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...

Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...

Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...

... the HECT protein, E6-AP and ... suggests that this E2 is ... of non-""N-end rule"" protein substrates ... proteins as well as the ...

Biology Products:

Rabbit Anti-ICAD / DFF45 (NT) Polyclonal Antibody, Unconjugated from ProSci, Inc Rabbit Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119] NON-neutralizing Polyclonal Antibody, Unconjugated from Cell Sciences Rabbit Anti-Human BAR Antibody, Unconjugated from CHEMICON Anti-UbcH7 Antibody, Unconjugated from CHEMICON

Abaxis Reports Record Revenues and Operating Income for the Second Quarter of F...(NC. Condensed Consolidated Statements...)